A very long-acting IL-15: implications for the immunotherapy of cancer.
John A HangaskyWei ChenSigrid P DuboisAnusara DaenthanasanmakJürgen R MüllerRalph ReidThomas A WaldmannDaniel V SantiPublished in: Journal for immunotherapy of cancer (2022)
that elicits prolonged expansion of target immune cells and high anticancer activity, especially when administered in combination with a suitable immuno-oncology agent.